Home  ›  France  ›  Cellectis

Cellectis insider transactions

Healthcare · EPA · France
Net insider signal · last quarter
Selling
Share price & insider trades · last quarter▲ buy   ▼ sell
€ 4.3€ 2.210 Apr09 Jul

Insiders were sellers over the last quarter — 5 sales, no buys — a net €4.2M of selling. Most recent filing: 29 May 2026.

Net insider flow · last quarter
-€4.2M0 buys · 5 sells
Insider profiles
+●.●% avg 3m · win rate

Transactions

DateInsiderRoleTypeValue
29 May 2026André Choulikadirecteur généralSell€2,590,000
29 May 2026David SourdiveVice-Président Exécutif CMC & ManufacturingSell€100,298
29 May 2026André Choulikadirecteur généralSell€1,295,000
28 May 2026David SourdiveVice-Président Exécutif CMC & Manufacturing▼ Sell€157,525
27 May 2026David SourdiveVice-Président Exécutif CMC & Manufacturing▼ Sell€38,749
Showing older filings · the 3 most recent are subscriber-only
Visit the website →

Under the EU Market Abuse Regulation (MAR), executives and board members (PDMRs) at French-listed companies must disclose dealings in their company's shares to AMF. Insider Transaction Terminal aggregates these filings daily, filters out the noise and gives you the trades that actually matter.